메뉴 건너뛰기




Volumn 51, Issue 1323, 2009, Pages 81-82

Generic drugs revisited
[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; CLARITHROMYCIN; DIURETIC AGENT; GENERIC DRUG; LAMOTRIGINE; LEVOTHYROXINE; LEVOTHYROXINE SODIUM; OMEPRAZOLE; PROTON PUMP INHIBITOR; TOPIRAMATE; WARFARIN;

EID: 70350239875     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey
Times cited : (4)

References (9)
  • 1
    • 0037078211 scopus 로고    scopus 로고
    • Generic drugs
    • Generic drugs. Med Lett Drugs Ther 2002; 44:89.
    • (2002) Med Lett Drugs Ther , vol.44 , pp. 89
  • 2
    • 57549093120 scopus 로고    scopus 로고
    • Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: A systematic review and meta-analysis
    • AS Kesselheim et al. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA 2008; 300:2514.
    • (2008) JAMA , vol.300 , pp. 2514
    • Kesselheim, A.S.1
  • 3
    • 62949127574 scopus 로고    scopus 로고
    • Generic versus non-generic formulation of extended-release clarithromycin in patients with community-acquired respiratory tract infections: A prospective, randomized, comparative, investigator-blind, multicentre study
    • JR Snyman et al. Generic versus non-generic formulation of extended-release clarithromycin in patients with community-acquired respiratory tract infections: a prospective, randomized, comparative, investigator-blind, multicentre study. Clin Drug Investig 2009; 29:265.
    • (2009) Clin Drug Investig , vol.29 , pp. 265
    • Snyman, J.R.1
  • 4
    • 70350218630 scopus 로고    scopus 로고
    • Generic omeprazole delayed-release capsules: In vitro performance evaluations
    • T Moore et al. Generic omeprazole delayed-release capsules: in vitro performance evaluations. Drug Dev Ind Pharm 2009; 35:917.
    • (2009) Drug Dev Ind Pharm , vol.35 , pp. 917
    • Moore, T.1
  • 5
    • 0035832753 scopus 로고    scopus 로고
    • What is going on with levothyroxine
    • What is going on with levothyroxine. Med Lett Drugs Ther 2001; 43:57.
    • (2001) Med Lett Drugs Ther , vol.43 , pp. 57
  • 6
    • 4944226610 scopus 로고    scopus 로고
    • Generic levothyroxine
    • Generic levothyroxine. Med Lett Drugs Ther 2004; 46:77.
    • (2004) Med Lett Drugs Ther , vol.46 , pp. 77
  • 7
    • 67650831241 scopus 로고    scopus 로고
    • Effects of antiepileptic drug substitutions on epileptic events requiring acute care
    • KL Rascati et al. Effects of antiepileptic drug substitutions on epileptic events requiring acute care. Pharmacotherapy 2009; 29:769.
    • (2009) Pharmacotherapy , vol.29 , pp. 769
    • Rascati, K.L.1
  • 8
    • 67649499946 scopus 로고    scopus 로고
    • The risks and costs of multiple-generic substitution of topiramate
    • MS Duh et al. The risks and costs of multiple-generic substitution of topiramate. Neurology 2009; 72:2122.
    • (2009) Neurology , vol.72 , pp. 2122
    • Duh, M.S.1
  • 9
    • 45949086485 scopus 로고    scopus 로고
    • Clinical consequences of generic substitution of lamotrigine for patients with epilepsy
    • J LeLorier et al. Clinical consequences of generic substitution of lamotrigine for patients with epilepsy. Neurology 2008; 70:2179.
    • (2008) Neurology , vol.70 , pp. 2179
    • Lelorier, J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.